Journal of Archives in Military Medicine

Published by: Kowsar

Current Infection Control Recommendations for Prion Disease; A Difficult Problem for the Deployed Personnel of the Armed Forces

Leigh G. Cooper 1 , 2 , * and Suresh J. Antony 1 , 2
Authors Information
1 Department of Biology, New Mexico State University, Las Cruces, USA
2 Department of Medicine, Burrell College of Medicine, Las Cruces, USA
Article information
  • Journal of Archives in Military Medicine: December 2017, 5 (4); e12607
  • Published Online: December 2, 2017
  • Article Type: Review Article
  • Received: May 5, 2017
  • Revised: November 7, 2017
  • Accepted: November 18, 2017
  • DOI: 10.5812/jamm.12607

To Cite: Cooper L G, Antony S J. Current Infection Control Recommendations for Prion Disease; A Difficult Problem for the Deployed Personnel of the Armed Forces, J Arch Mil Med. 2017 ; 5(4):e12607. doi: 10.5812/jamm.12607.

Abstract
Copyright © 2017, Journal of Archives in Military Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Epidemiology
3. Infection Control Issues Associated with Prion Disease
4. Conclusion
5. Recommendations for Prospective Research for the Military in Prion Disease
Acknowledgements
Footnote
References
  • 1. Kasper D, Fauci A. Harrisons infectious disease. 2 , editor. New York, United States: McGraw Hill Education Company; 2013. p. 1058-66.
  • 2. Weber DJ, Rutala WA. Managing the risk of nosocomial transmission of prion diseases. Curr Opin Infect Dis. 2002;15(4):421-5. doi: 10.1097/00001432-200208000-00011. [PubMed: 12130940].
  • 3. Lee HS, Goldfarb LG. Global distribution of Fatal familial insomnia: founder or recurrent mutations. Neurogenetics. 2008;9(4):301-2. doi: 10.1007/s10048-008-0135-3. [PubMed: 18568368].
  • 4. de Pedro-Cuesta J, Mahillo-Fernandez I, Rabano A, Calero M, Cruz M, Siden A, et al. Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry. 2011;82(2):204-12. doi: 10.1136/jnnp.2009.188425. [PubMed: 20547628].
  • 5. Chen C, Dong XP. Epidemiological characteristics of human prion diseases. Infect Dis Poverty. 2016;5(1):47. doi: 10.1186/s40249-016-0143-8.
  • 6. Lee J, Kim SY, Hwang KJ, Ju YR, Woo HJ. Prion diseases as transmissible zoonotic diseases. Osong Public Health Res Perspect. 2013;4(1):57-66. doi: 10.1016/j.phrp.2012.12.008. [PubMed: 24159531].
  • 7. de Mendoza C, Altisent C, Aznar JA, Batlle J, Soriano V. Emerging viral infections-a potential threat for blood supply in the 21st century. AIDS Rev. 2012;14(4):279-89. [PubMed: 23258302].
  • 8. Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18(6):901-7. doi: 10.3201/eid1806.120116. [PubMed: 22607808].
  • 9. Bradford BM, Piccardo P, Ironside JW, Mabbott NA. Human prion diseases and the risk of their transmission during anatomical dissection. Clin Anat. 2014;27(6):821-32. doi: 10.1002/ca.22403. [PubMed: 24740900].
  • 10. Baxter RL, Baxter HC, Campbell GA, Grant K, Jones A, Richardson P, et al. Quantitative analysis of residual protein contamination on reprocessed surgical instruments. J Hosp Infect. 2006;63(4):439-44. doi: 10.1016/j.jhin.2006.03.011. [PubMed: 16772103].
  • 11. Foutz A, Appleby BS, Hamlin C, Liu X, Yang S, Cohen Y, et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann Neurol. 2017;81(1):79-92. doi: 10.1002/ana.24833. [PubMed: 27893164].
  • 12. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real time quaking induced conversion. Nat Med. 2011;17(2):175-8. doi: 10.1038/nm.2294. [PubMed: 21278748].
  • 13. The World Organisation for Animal Health . World organizaition for animal health. 2013. Available from: http://www.oie.int/animal-health-in-the-world/bse-specific-data/number-of-reported-cases-worldwide-excluding-the-united-kingdom/.
  • 14. Alpers MP. The epidemiology of kuru: monitoring the epidemic from its peak to its end. Philos Trans R Soc Lond B Biol Sci. 2008;363(1510):3707-13. doi: 10.1098/rstb.2008.0071. [PubMed: 18849286].
  • 15. Hinckley GT, Johnson CJ, Jacobson KH, Bartholomay C, McMahon KD, McKenzie D, et al. Persistence of pathogenic prion protein during simulated wastewater treatment processes. Environ Sci Technol. 2008;42(14):5254-9. doi: 10.1021/es703186e. [PubMed: 18754377].
  • 16. Peden AH, Head MW, Ironside JW. Prions and Diseases. In: Zhou WQ, Gambetti P, editors. 2. New York: Springer; 2013. Risk of transmission of creutzfeldt jakob disease by blood transfusion; p. 121-38. doi: 10.1007/978-1-4614-5338-3_8.
  • 17. Desjardins J. U.S. Military personnel deployments by country. Gastown, Vancouver; 2017. Available from: http://www.visualcapitalist.com/u-s-military-personnel-deployments-country/.
  • 18. Douet JY, Lacroux C, Aron N, Head MW, Lugan S, Tillier C, et al. Distribution and quantitative estimates of variant creutzfeldt jakob disease prions in tissues of clinical and asymptomatic patients. Emerg Infect Dis. 2017;23(6):946-56. doi: 10.3201/eid2306.161734.
  • 19. Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, Ironside JW, et al. Variant CJD. 18 years of research and surveillance. Prion. 2014;8(4):286-95. doi: 10.4161/pri.29237. [PubMed: 25495404].
  • 20. Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry. 2005;76(7):906-19. doi: 10.1136/jnnp.2004.048660. [PubMed: 15965195].
  • 21. Thomas JG, Chenoweth CE, Sullivan SE. Iatrogenic creutzfeldt Jakob disease via surgical instruments. J Clin Neurosci. 2013;20(9):1207-12. doi: 10.1016/j.jocn.2013.01.007. [PubMed: 23896549].
  • 22. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med. 1999;5(4):240-3. [PubMed: 10448646].
  • 23. Peretz D, Supattapone S, Giles K, Vergara J, Freyman Y, Lessard P, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol. 2006;80(1):322-31. doi: 10.1128/JVI.80.1.322-331.2006. [PubMed: 16352557].
  • 24. Lipscomb IP, Sihota AK, Botham M, Harris KL, Keevil CW. Rapid method for the sensitive detection of protein contamination on surgical instruments. J Hosp Infect. 2006;62(2):141-8. doi: 10.1016/j.jhin.2005.07.008. [PubMed: 16290315].
  • 25. Fichet G, Antloga K, Comoy E, Deslys JP, McDonnell G. Prion inactivation using a new gaseous hydrogen peroxide sterilization process. J Hosp Infect. 2007;67(3):278-86. doi: 10.1016/j.jhin.2007.08.020. [PubMed: 17942185].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments